BioSpace News Archive

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today reported financial results for its fiscal first quarter ended December 31, 2021.

Cardinal Health announced that its Board of Directors approved a quarterly dividend of $0.4908 per share.

Varex Imaging Corporation announced its unaudited financial results for the first quarter of fiscal year 2022.

Veracyte, Inc. (Nasdaq: VCYT) announced today that Marc Stapley, chief executive officer, and Rebecca Chambers, chief financial officer, will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference.

Certara, Inc., a global leader in biosimulation, announced that it will release financial results for the fourth quarter and full year of 2021 after the market close on Tuesday, March 1st, 2022.

Cerus Corporation (Nasdaq: CERS) announced today that its fourth quarter and full-year 2021 financial results will be released on Tuesday, February 22, 2022, after the close of the stock market.

Ora, Inc., the world’s leading partner for ophthalmic pharmaceutical and device development, announced that distinguished ophthalmologist and researcher, Dr. Gustavo De Moraes, MD, PhD, MPH, has accepted the role of Chief Medical Officer.

Researchers from National Institute of Standards and Technology, Baylor College of Medicine and DNAnexus, Inc., together with other members of the Genome in a Bottle consortium, announce the publication of a comprehensive benchmark dataset comprising 273 challenging medically relevant autosomal genes that are associated with the development of diseases such as homocystinuria and spinal muscular atrophy.

Arcturus Therapeutics Holdings Inc. announced that members of the Company’s management team will be participating in the SVB Leerink 11th Annual Global Healthcare Conference 2022.

BioSkryb Genomics, a leader of single-cell genome amplification, and ALS Automated Lab Solutions GmbH, developers of a multi-patented spatial single cell and colony picking technology platform, today announced a U.S. distribution agreement to power comprehensive single cell plus spatial genomic analysis.